|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Jasper Therapeutics (NASDAQ: JSPR) through any online brokerage.
There are no as such competitors for Jasper Therapeutics.
The latest price target for Jasper Therapeutics (NASDAQ: JSPR) was reported by William Blair on October 21, 2021. The analyst firm set a price target for 0.00 expecting JSPR to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
The stock price for Jasper Therapeutics (NASDAQ: JSPR) is $11.79 last updated Mon Oct 25 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Jasper Therapeutics.
Jasper Therapeutics’s $Q3 earnings are confirmed for after-market on $November 5, 2021.
There is no upcoming split for Jasper Therapeutics.
Jasper Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.